This is your chance to get involved - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

This is your chance to get involved


Pharmaceutical Technology Europe
Volume 22, Issue 6


Fedra Pavlou
Have you ever come across a new technology, process or problem in your profession and wanted to tell others or learn more about it? Or have you read through your issue of PTE and wished that the editors would publish more articles on a particular subject? If so, I'd really like to hear from you. This month sees the launch of PTE's annual readership survey ( http://www.pharmtech.com/survey2010). I always look forward to reading the results of this survey because it helps me to better understand what it is that you want from your monthly magazine and digital products. Ultimately, it helps me to do my job better and that is to provide the information that you want to read at the right time and in the right format.

If the opportunity of having direct input into PTE's editorial direction isn't enough of an incentive for you, then let me also tell you that all survey respondents will be entered into a prize draw to win an iPod Touch. The winner will be announced on our website ( http://www.pharmtech.com) in July as well as in PTE's eNewsletter.

I urge you take the time to complete this short online form, which is available on our website ( http://www.pharmtech.com/survey2010) and I guarantee it should take no longer than 5 minutes of your time. If you don't take part, I'll assume you think we're great just the way we are :-)

As always, thank you for your continued support.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology Europe,
Click here